Bradley wiggins daily mail

You're referring to the infamous article published by the Daily Mail in 2012, which sparked a major controversy in the cycling world.

The article, titled "Wiggins' TUEs: The truth behind Bradley Wiggins' medical exemption", suggested that Bradley Wiggins, the British professional road racing cyclist, had used therapeutic use exemptions (TUEs) to gain an unfair advantage in competition. The article claimed that Wiggins had used corticosteroids to treat a pollen allergy, which could have improved his performance.

The article was widely criticized by the cycling community, with many accusing the Daily Mail of sensationalism and lack of understanding of the medical context. Wiggins himself denied any wrongdoing, stating that he had used the TUEs to treat a legitimate medical condition, and that the medication had not enhanced his performance.

The controversy led to an investigation by the UK Anti-Doping Agency (UKAD), which ultimately cleared Wiggins of any wrongdoing. The investigation found that Wiggins had used the TUEs to treat a legitimate medical condition, and that there was no evidence to suggest that he had used the medication to gain an unfair advantage.

The incident highlighted the importance of transparency and understanding in the use of TUEs in professional sports. It also led to a wider discussion about the use of performance-enhancing drugs in cycling and other sports, and the need for stricter regulations and greater transparency in the use of TUEs.

In the end, the controversy surrounding the Daily Mail article did not tarnish Wiggins' reputation as a cyclist, and he remains one of the most successful and respected riders in the sport.